INOVIO PHARMACEUTICALS, INC. (INO) Return on equity 2016–2025
INOVIO PHARMACEUTICALS, INC. (INO) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-352.5%FY2025 · since FY2016: -59.8% → -352.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -352.5% | -196.0 pp |
| FY2024 | -156.6% | -41.4 pp |
| FY2023 | -115.1% | +10.7 pp |
| FY2022 | -125.8% | -49.9 pp |
| FY2021 | -76.0% | -39.9 pp |
| FY2020 | -36.1% | +3438.6 pp |
| FY2019 | -3474.7% | -3363.2 pp |
| FY2018 | -111.5% | -49.6 pp |
| FY2017 | -61.9% | -2.1 pp |
| FY2016 | -59.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice